Get Quote
730 people are quoting
X

Ursodeoxycholic Acid

3 week ago
2 0
Product details

What is Ursodeoxycholic Acid Powder?

Ursodeoxycholic Acid (UDCA) is a hydrophilic, dihydroxy bile acid naturally found in human bile, synthesized as a white crystalline powder (molecular formula: C₂₄H₄₀O). It modulates bile composition by reducing cholesterol saturation and enhancing hepatobiliary detoxification17. XJESON’s pharmaceutical-grade UDCA powder (CAS 128-13-2) is produced via patented catalytic hydrogenation, achieving ≥99% HPLC-verified purity with ultra-low endotoxins (<0.1 EU/mg), suitable for injectables and oral formulations.

 

Ursodeoxycholic Acid (5)

 


Technical Specifications

Parameter

Specification

Molecular Formula

C₂₄H₄₀O

Appearance

White crystalline powder

Solubility

Ethanol >100mg/ml; Insoluble in water

Storage

-20°C in vacuum-sealed bags

Shelf Life

36 months

Heavy Metals

<10ppm (ICH Q3D compliant)


 Key Benefits & Applications

 1. Pharmaceutical raw materials and Pharmaceutical chemicals

  • PBC (Primary Biliary Cholangitis) Treatment
    • Mechanism: Replaces toxic bile acids, inhibits apoptosis of hepatocytes, and reduces inflammatory markers.
    • Dosage: 10–15 mg/kg/day in tablets/capsules; improves survival rates in early-stage PBC.
  • Cholesterol Gallstone Dissolution
    • Efficacy: Dissolves X-ray translucent stones (<5 mm diameter) with 70% success rate at 10 mg/kg/day.
    • Patient Selection: Requires a functional gallbladder and non-calcified stones.
  • NAFLD/NASH Therapy
    • Emerging Use: Reduces liver fibrosis and steatosis in Phase III trials (30 mg/kg/day).

 2. Health care material & Synergistic Formulations

  • Liver Health Supplements: Combined with silymarin (milk thistle) or artichoke extract to enhance bile flow and reduce biliary sludge (32.4% dissolution rate in clinical studies).
  • Metabolic Health: Lowers serum cholesterol and improves lipid profiles in metabolic syndrome models.

 Technical Specifications (XJESON UDCA Powder)

Parameter

Specification

Compliance

Purity

≥99% (HPLC)

USP/EP, ICH Q7

Heavy Metals

<10 ppm

ICH Q3D

Endotoxins

<0.1 EU/mg

Injectable-grade

Solubility

Ethanol >100 mg/ml; Insoluble in water

Optimized for encapsulation

Shelf Life

36 months at -20°C

Accelerated stability tested


XJESON Quality Assurance

  • Traceability: Batch-specific COA with HPLC/MS, NMR, and residual solvent reports47.
  • Stability Studies: 24-month accelerated testing confirms potency retention >98%9.
  • Scalability: MOQs from 1kg (R&D) to 10MT (commercial); lead time 14 days15.

Why Partner with XJESON?

XJESON’s UDCA powder enabled 30% faster dissolution in our enteric-coated tablets versus competitors.
R&D Director, EU Top-10 Pharma

  1. End-to-End Compliance: Full documentation for FDA/EMA audits.
  2. Technical Support: Free formulation consulting + preclinical data packages.
  3. Supply Resilience: Dual sourcing from ISO 13485-certified plants (China + EU).

 FAQs for B2B Clients

Q1: What purity standards does XJESON UDCA powder meet?

A: All batches comply with FDA/EMA/WHO-GMP guidelines. Purity ≥99% verified by HPLC/MS, with residual solvent limits per ICH Q3C.

Q2: Can UDCA powder be used in NAFLD nutraceuticals?

A: Yes. It is clinically validated for NAFLD support at 250–500 mg/day doses, often combined with artichoke or green tea extracts for synergistic hepatoprotection.

Q3: How does synthetic UDCA compare to animal-derived sources?

A: XJESON’s synthetic process eliminates pathogen risks (e.g., from bear bile) and ensures batch consistency. Cost is 20% lower than bio-extracted UDCA.

Q4: Is UDCA effective for bile reflux gastritis?

A: Yes. It displaces toxic bile acids in the stomach, reducing mucosal injury at 300 mg/day doses.

Q5: What documentation supports regulatory submissions?

A: Full DMF, COA (HPLC/NMR), and 24-month stability data provided. REACH/ISO 13485 certifications available for EU/NA markets.

Q6: How to store bulk UDCA powder for long-term stability?

A: Store at -20°C in vacuum-sealed bags with oxygen absorbers. Avoid moisture and light exposure.

Q7: Can you customize particle size for tablet formulation?

A: Yes. Options: 50–200 μm (direct compression) or micronized (<50 μm for enhanced bioavailability).

Contact Now

If you are interested in the product, contact 2bvideo.com for more information for more information

To:
Xi'an XJeson Biotech Co., Ltd
Message:
Submit
Disclaimer:

The information of 2bvideo.com limited shown above is provided by the user or collected on the network. Video 2B does not guarantee the authenticity,accuracy and legitimacy of 2bvideo.com limited information. Video 2B does not involve legal relationships and disputes between users arising from transactions other than secured transactions on this website. Disputes shall be settled by you through negotiation. If you are the person in charge or relevant employee of this enterprise, if you find that the enterprise information is incorrect or want to manage thiscompany, please contact us jacklee1558@gmail.com, after you claim the enterprise, you can obtain management permission, publish supplyand demand information, bring consulting orders, and remove page advertisements.

Audited supplier
3 year
Address: Xian, China


Main Product: Furit & Vegetable Powder, Cosmetic Raw Material, Pharmaceutical Raw Materials, Flavors & Fragrances, Health Care Material , Herbal Extract

Disclaimer:
The information of 2bvideo.com limited shown above is provided by the user or collected on the network. Video 2B does not guarantee the authenticity,accuracy and legitimacy of 2bvideo.com limited information. Video 2B does not involve legal relationships and disputes between users arising from transactions other than secured transactions on this website. Disputes shall be settled by you through negotiation. If you are the person in charge or relevant employee of this enterprise, if you find that the enterprise information is incorrect or want to manage thiscompany, please contact us jacklee1558@gmail.com, after you claim the enterprise, you can obtain management permission, publish supplyand demand information, bring consulting orders, and remove page advertisements.
Content Us